<unk>  refers to a two-week regimen consisting of rituximab,cyclophosphamide, doxorubicin (hydroxydaunorubicin, vincristine (Oncovin), etoposide, and prednisone used to treat diffuse large B-cell lymphoma.
R-CHOEP-14 regimen
ICE-R regimen
R-CDOP regimen
FLAMSA-MEL regimen
FMC-R regimen
MINE-R regimen
ProMACE-MOPP regimen
DHAX-R regimen